Clinical Trials

A Phase 2 Study of the Safety, Tolerability, and Efficacy of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis


Study ID
Incyte INCB 50465-201

NCT Number
NCT02718300 (Click on the NCT number for more information about the trial)

Research Study Number
2016-0551

Principle Investigator
Dr. James McCloskey

Phase
II

Sponsor
Incyte


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now